Modus Therapeutics
Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does Modus Therapeutics use?+
Modus Therapeutics uses 19 technologies including Bootstrap, Cookie Control, Google Analytics.
What industry is Modus Therapeutics in?+
Modus Therapeutics operates in the Biotechnology industry.
Where is Modus Therapeutics based?+
Modus Therapeutics is headquartered in Sweden.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026